Comparative study of muromonab-CD3 (OKT3) versus Daclizumab (Zenapax) in cardiac transplantation at our center

Transplantation Proceedings

Volumn 37, Issue 3, 2005, Pages 1548-1549

  Campos, A ^a,b   Lage, E ^a   Hinojosa, R ^a   Ordonez A ^a   Cisneros, J M ^a   Cabezon S ^a   Gomez S ^a   Aguilera, A ^a   Arana, E ^a   Cayuela, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID; OKT 3; STEROID; TACROLIMUS;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SIDE EFFECT;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MUROMONAB-CD3; RETROSPECTIVE STUDIES;

EID: 21044432044     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.023     Document Type: Conference Paper

References (3)

1. Hunt SA, Schroeder JS, Berry JG: Cardiac transplantation, mechanical ventricular support, and endomyocardial biopsy. In Fuster V, et al (eds): Hurst's The Heart Manual of Cardiology, 10th Ed (Spanish). Madrid: McGraw-Hill; 2002, p 741
2. M.G. Crespo-Leiro, J.L. Rodriguez-Lambert, J.L. Segovia Study of the safety and tolerability of Simulect® (Basiliximab) versus OKT3 in heart transplantation J Heart Lung Transplant 22 2003 S141
3. A. Beniaminovitz, S. Itescu, K. Lietz Prevention of rejection in cardiac transplantation by blockade of the interleukin2 receptor with a monoclonal antibody N Engl J Med 342 2000 647